Literature DB >> 17164117

Hepatitis C virus: virology and experimental systems.

Chen Liu1.   

Abstract

Over the past several years, significant progress has been made toward the understanding of hepatitis C virus, especially the development of in vitro cell culture models. The scientific community now has the tools to gain a better understanding of the virus, which should translate into better clinical therapeutic modalities. Many new drugs are currently being evaluated, and a few are already undergoing clinica trials. This article focuses on the current advances in hepatitis C virus virology.

Entities:  

Mesh:

Year:  2006        PMID: 17164117     DOI: 10.1016/j.cld.2006.08.018

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  2 in total

1.  Screening compounds against HCV based on MAVS/IFN-β pathway in a replicon model.

Authors:  Qiu-Xia Fu; Li-Cui Wang; Shuai-Zheng Jia; Bo Gao; Yong Zhou; Juan Du; Ying-Li Wang; Xiao-Hui Wang; Jian-Chun Peng; Lin-Sheng Zhan
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

2.  Clinical significance of activity of ALT enzyme in patients with hepatitis C virus.

Authors:  Onder Akkaya; Murat Kiyici; Yusuf Yilmaz; Engin Ulukaya; Omer Yerci
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.